Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study not approved
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fairview Health Services | OTHER |
Not provided
Not provided
Not provided
A cross-sectional study to explore the relationship between clinically assessed pulmonary function test (PFT) measures and transdiaphragmatic (Pdi) measures in Duchenne muscular dystrophy (DMD) as well as to explore the relationship between sniff nasal inspiratory pressure (SNIP) and transdiaphragmatic (Pdi) measures in Duchenne muscular dystrophy.
Two small balloons, which are attached to small, flexible tubes, will be put into the esophagus and stomach through your nose. Each balloon is about 2 inches long (deflated) and about the width of a pencil tip. To reduce any discomfort with this procedure, lidocaine gel or spray will be put into the subject's nose and administered to the back of the throat before the balloon. In addition, swallowing water during the procedure will help to reduce any gagging sensation and will assure that the balloon goes into the esophagus. Proper placement of the catheters will be determined using normal tidal breathing against an occluded mouthpiece with a nose clip. Once proper placement is ensured, the catheters will remain in place during your normal PFT maneuvers. Additionally, while the gastric and esophageal balloon catheters are in place, the subject will be asked to perform a maximal sniff maneuver (SNIP) while one nostril is occluded with a plug containing a distal pressure measurement catheter to measure airway pressure. The distal end of the pressure catheter will be connected to a hand held pressure meter to display peak pressure and to provide you visual feedback. This maneuver will be performed 10 times.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Measurement of Pdi | Experimental | Two small balloons, which are attached to small, flexible tubes, will be put into the esophagus (food tube) and stomach through the nose. Each balloon is about 2 inches long (deflated) and about the width of a pencil tip. A gastric balloon will be inserted into subject's stomach while an esophageal balloon will be inserted into the subject's esophagus. To reduce any discomfort with this procedure, lidocaine gel or spray will be put into the subject's nose and administered to the back of the throat before the balloon. In addition, swallowing water during the procedure will help to reduce any gagging sensation and will assure that the balloon goes into the esophagus. |
|
| Measurement of SNIPs | Experimental | While the gastric and esophageal balloon catheters are in place, the subject will be asked to perform a maximal sniff maneuver (SNIP) while one nostril is occluded with a plug containing a nasal pressure transducer to measure airway pressure during maximal inspiration. The distal end of the pressure catheter will be connected to a hand held pressure meter to display peak pressure and to provide you visual feedback. This maneuver will be performed 10 times. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Esophageal Balloon | Diagnostic Test | Small flexible catheter with deflated balloon at distal end to be inserted into the esophagus through the nose |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of Pdi | For all subjects Pdi (transdiaphragmatic pressure measures) will be assessed with gastric and esophageal balloons | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of SNIP | For all subjects, SNIP (sniff nasal inspiratory pressures) will be assessed with a nasal pressure transducer | 1 year |
| Evaluation of FVC | For all subjects, FVC (forced vital capacity) will be assessed with spirometry |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eric M Snyder, PhD | University of Minnesota | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D020388 | Muscular Dystrophy, Duchenne |
| ID | Term |
|---|---|
| D009136 | Muscular Dystrophies |
| D020966 | Muscular Disorders, Atrophic |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Cross-sectional
Not provided
Not provided
Not provided
Not provided
| Gastric Balloon | Diagnostic Test | Small flexible catheter with deflated balloon at distal end to be inserted into the stomach through the nose |
|
| Nasal Pressure Transducer | Diagnostic Test | Pressure transducer inserted into nasal plug |
|
| 1 year |
| Evaluation of FEV1 | For all subjects, FEV1 (forced expiratory volume in 1 second) will be assessed with spirometry | 1 year |
| Evaluation of FEFmax | For all subjects, FEFmax (maximal forced expiratory flow) will be assessed with spirometry | 1 year |
| Evaluation of FEF25-75 | For all subjects, FEF25-75 (the average forced expiratory flow during the mid (25 - 75%) portion of the FVC) will be assessed with spirometry | 1 year |
| Evaluation of FEF50 | For all subjects, FEF50 (forced expiratory flow at 50% of FVC) will be assessed with spirometry | 1 year |
| Evaluation of MIP | For all subjects, MIP (maximal inspiratory pressure) will be assessed with spirometry | 1 year |
| Evaluation of MEP | For all subjects, MEP (maximal expiratory pressure) will be assessed with spirometry | 1 year |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D040181 | Genetic Diseases, X-Linked |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |